Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Capital Expenditures history
Currency unavailable · from the cash flow
No Capital Expenditures data reported for this period type.
Capital Expenditures vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $975K USD | +139.9% | +26.0% | 0.3% | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $401K USD | -77.7% | -35.3% | 5.4% |
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | $219K USD | +33.5% | +371.0% | — |
| LTM Mar 2026 | $116K USD | -58.6% | +12.9% | — | |
| LTM Mar 2026 | $81K USD | -99.8% | -43.2% | 1.0% | |
| LTM Mar 2026 | $69K USD | -81.1% | -37.6% | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | — | — | — | — | — |
| Peer median (excluding ODTX) | — | -68.1% | -11.2% | 0.3% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.